These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29805248)

  • 21. Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis.
    Yao N; Fu S; Wu Y; Tian Z; Feng Y; Li J; Luo X; Yang Y; Ji F; Chen Y; Liu J; Zhao Y; Chen T
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1197-1206. PubMed ID: 36082797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia.
    Foaud HM; Maklad S; Gmal El Din A; Mahmoud F
    Arab J Gastroenterol; 2019 Mar; 20(1):8-13. PubMed ID: 30857834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study.
    Mpody C; Thompson P; Tabala M; Ravelomanana NLR; Malongo F; Kawende B; Behets F; Okitolonda E; Yotebieng M;
    PLoS One; 2019; 14(5):e0216293. PubMed ID: 31071145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals.
    Godbole G; Irish D; Basarab M; Mahungu T; Fox-Lewis A; Thorne C; Jacobs M; Dusheiko G; Rosenberg WM; Suri D; Millar AD; Nastouli E
    BMC Pregnancy Childbirth; 2013 Dec; 13():222. PubMed ID: 24289183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission].
    Lu JF; Liu YL; Ma LN; Cao ZH; He ZM; Jin Y; Zhang SB; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):821-5. PubMed ID: 26743241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
    Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
    Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
    Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
    J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo.
    Ekouevi DK; Larrouy L; Gbeasor-Komlanvi FA; Mackiewicz V; Tchankoni MK; Bitty-Anderson AM; Gnatou GY; Sadio A; Salou M; Dagnra CA; Descamps D; Coffie PA
    BMC Infect Dis; 2020 Nov; 20(1):839. PubMed ID: 33183254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
    Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
    J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
    Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
    J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, Infectivity, and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission.
    Amsalu A; Ferede G; Eshetie S; Tadewos A; Assegu D
    J Pregnancy; 2018; 2018():8435910. PubMed ID: 30174956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying gaps across the cascade of care for the prevention of HBV mother-to-child transmission in Burkina Faso: Findings from the real world.
    Guingané AN; Bougouma A; Sombié R; King R; Nagot N; Meda N; Van de Perre P; Tuaillon E
    Liver Int; 2020 Oct; 40(10):2367-2376. PubMed ID: 32633864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal Screening for and Prevalence of Hepatitis B Surface Antigen in Pregnant Women and Prevention of Transmission to Infants Born to Infected Mothers-Guam, 2014.
    Abara WE; Cha S; Malik T; DeSimone MS; Schillie S; Collier M; Schumann B; Klemme M; Kamb M
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):290-295. PubMed ID: 28992071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
    Xu J; Tao LL; Ma LX
    J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B Virus Infection in Pregnancy: An Update on Evidence-Based Management.
    Sirilert S; Tongsong T
    Obstet Gynecol Surv; 2020 Sep; 75(9):557-565. PubMed ID: 32997148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Getting to zero mother-to-child transmission of hepatitis B virus: dream and challenge].
    Yin XR; Liu ZH; Liu ZH; Li J; Zhuang H; Dou XG; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):262-265. PubMed ID: 29996336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.